BEIJING, July 2 China Medical Technologies,Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitrodiagnostic ("IVD") company, today announced that it will report its unauditedfinancial results for the first fiscal quarter ("1Q FY2010") ended June 30,2010 before the U.S. market opens on August 16, 2010. The Company's 2010fiscal year ends on March 31, 2011.
The Company's senior management will host an earnings conference call at8:00 a.m. U.S. Eastern Time on August 16, 2010 (8:00 p.m. Beijing/Hong Kongtime on August 16, 2010).
A live webcast of the conference call will be available onhttp://ir.chinameditech.com .
A replay of this webcast will be available for one month on this website.
A telephone replay of the call will be available after the conclusion ofthe conference call through 10:00 a.m. U.S. Eastern Time on August 17, 2010.The dial-in details for the replay are as follows:
About China Medical Technologies, Inc.
China Medical Technologies, Inc. is a leading China-based advanced IVDcompany using molecular diagnostic technologies including Fluorescent in situHybridization (FISH) technology and Surface Plasmon Resonance (SPR) technologyas well as Enhanced Chemiluminescence Immunoassay (ECLIA) technology, animmunodiagnostic technology to develop, manufacture and distribute diagnosticproducts for the detection of various cancers, diseases and disorders. TheCompany generates all revenues in China by selling diagnostic consumablesincluding FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitalswhich are recurring users of the consumables for their patients. The Companysells FISH probes and SPR chips to large hospitals through its direct salesforce and ECLIA reagent kits to small and mid-size hospitals throughdistributors. For more information, please visit http://www.chinameditech.com .Conference Call The dial-in details for the live conference call are as follows: - U.S. Toll Free Number: 1-866-543-6407 - International Dial-in Number: 1-617-213-8898 Passcode: CMEDCALL
SOURCE China Medical Technologies, Inc.